Scientific operating system

Our Standard

Evidence. Precision. Progress. The site is designed to show not only what trūth believes, but why, on what evidence, and with what uncertainty.

iCompany in formation · No IND filed · No trial authorized · No product approved or available for sale

Claim discipline

Six evidence states.

Every scientific statement is visibly assigned to one state so observation, inference, hypothesis, and planned research are not blended together.

Established External Evidence

Published research, regulatory documents, validated instruments, and accepted clinical knowledge.

Case Observation

Directly documented findings from source records, patient reporting, imaging, or clinician assessment.

Proposed Mechanism

A testable explanation that may organize future studies but is not presented as established fact.

Unresolved Question

A material uncertainty that affects interpretation, feasibility, safety, or regulatory strategy.

Planned Trial Endpoint

A prospective outcome measure selected before data collection and separated from exploratory analysis.

Regulatory Status

Precise statements concerning company formation, IND status, trial authorization, and product approval.

Decision principles

What governs development.

The company’s scientific and operational identity is built around explicit constraints rather than promotional optimism.

01

Patient Autonomy

Consent, context, dignity, privacy, and the right to withdraw are design requirements.

02

Safety Before Signal

A promising observation does not override cardiovascular, hepatic, psychiatric, or interaction risk.

03

Falsifiability

Trials must be able to show that the product or intervention does not work as hypothesized.

04

Transparent Record

Version history, limitations, negative findings, and conflicts remain part of the scientific record.

Publication standard

No certainty theater.

  • State the design honestlySingle-subject observations are not described as clinical efficacy.
  • Separate source from interpretationRecords, reported outcomes, and explanatory models remain distinguishable.
  • Show concurrent therapiesKesimpta, acupuncture, acetaminophen, and other treatments are not hidden as confounders.
  • Publish the open questionsThe site makes missing evidence visible rather than burying it in fine print.

Public product statement

Neither Belcopa nor NovusClarus is approved, available for sale, or established as safe or effective. The pages describe research concepts and proposed development pathways.

Governance

Leadership appointments pending.

trūth is assembling an independent scientific, clinical, regulatory, ethics, and operational leadership structure before assigning permanent executive roles.

Scientific Independence

Advisors must be able to disagree publicly and document material concerns.

Conflict Transparency

Financial, authorship, intellectual-property, and institutional interests are recorded.

Decision Traceability

Material product and study decisions retain rationale, evidence, dissent, and approval history.